CCN5 and cystic fibrosis: Our group previously showed that CCN5, also known as WNT1-inducible signaling pathway protein 2 (WISP-2), inhibits cardiac fibrosis (CF) through inhibition of endothelial–mesenchymal transition and trans-differentiation of FBs to MyoFBs [12–16].